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Long-term alcohol use can lead to alterations in brain structure and functions and,
in some cases, to neurodegeneration. Several mechanisms have been proposed to
explain ethanol (EtOH)-related brain injury. One of the most relevant mechanisms
of alcohol-induced neurodegeneration involves glutamatergic transmission, but their
exact role is not yet fully understood. We investigated the neurochemical mechanisms
underlying the toxicity induced by EtOH dependence and/or withdrawal by exposing
rat organotypic hippocampal slices to EtOH (100–300 mM) for 7 days and then
incubating the slices in EtOH-free medium for the subsequent 24 h. EtOH withdrawal
led to a dose-dependent CA1 pyramidal cell injury, as detected with propidium iodide
fluorescence. Electron microscopy of hippocampal slices revealed that not only EtOH
withdrawal but also 7 days chronic EtOH exposure elicited signs of apoptotic cell death
in CA1 pyramidal cells. These data were supported by electrophysiological recordings of
spontaneus Excitatory Post Synaptic Currents (sEPSCs) from CA1 pyramidal cells. The
average amplitude of sEPSCs in slices treated with EtOH for 7 days was significantly
increased, and even more so during the first 30 min of EtOH withdrawal, suggesting
that the initial phase of the neurodegenerative process could be due to an excitotoxic
mechanism. We then analyzed the expression levels of presynaptic (vGlut1, vGlut2, CB1
receptor, synaptophysin) and postsynaptic (PSD95, GluN1, GluN2A, GluN2B, GluA1,
GluA2, mGluR1 and mGluR5) proteins after 7 days EtOH incubation or after EtOH
withdrawal. We found that only GluA1 and mGluR5 expression levels were significantly
increased after EtOH withdrawal and, in neuroprotection experiments, we observed that
AMPA and mGluR5 antagonists attenuated EtOH withdrawal-induced toxicity. These
data suggest that chronic EtOH treatment promotes abnormal synaptic transmission
that may lead to CA1 pyramidal cell death after EtOH withdrawal through glutamate
receptors and increased excitotoxicity.
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INTRODUCTION
Alcohol addiction is a chronic, relapsing brain disease
characterized by mental and physical health problems with
devastating consequences. The World Health Organization
(WHO) estimates that there are about 208 million people with
alcoholism worldwide (4.1% of the population over 15 years of
age), about 2.3 million people die for a cause alcohol-related and
76.3 million have alcohol use disorders, with social and economic
cost, ranging from 1 to 6% of the Gross Domestic Product
(GDP) of a country (World Health Organization [WHO],
2014).
Chronic alcohol exposure and alcohol protracted
withdrawal causes profound neuroadaptive changes in
neuronal excitability and synaptic plasticity that are the
consequences of a complex interplay of biological vulnerability,
environmental exposure, and developmental factors (Koob and
Le Moal, 2008). The efficacies of current pharmacotherapies
targeting alcohol dependence are limited also because alcohol
affects diverse neurotransmitter systems in the brain (i.e.,
dopaminergic, GABAergic, glutamatergic and serotonergic
systems) (LeMarquand et al., 1994; Charlet et al., 2013).
Importantly, following long-term alcohol consumption,
the brain compensates the depressant effects of alcohol to
maintain homeostasis between inhibitory and excitatory
neurotransmission by increasing excitatory activity and reducing
inhibitory activity (Nam et al., 2012; Koob, 2013; Tabakoff and
Hoffman, 2013).
Glutamate plays a pivotal role in drug addiction, drug
self-administration, reward-related processes and relapse
(Kalivas and Volkow, 2005; Gass and Olive, 2008). Increased
glutamatergic neurotransmission and hyper-excitability during
withdrawal and abstinence are associated with an increased
risk for relapse (Tsai and Coyle, 1998), and changes in the
glutamatergic system after chronic alcohol intake has been
largely described (Nagy et al., 2005; Krupitsky et al., 2007)
and numerous reports have demonstrated the functional
relationship observed in EtOH dependent and withdrawn
animals and the glutamatergic transmission (Läck et al., 2007;
Marty and Spigelman, 2012; Gerace et al., 2016). Elevated levels
of glutamate has been measured in the medial prefrontal cortex
of alcoholic patients and alcohol-dependent rats during acute
withdrawal (Hermann et al., 2012). NMDA receptor alterations
and functioning have been described to contribute to neuronal
excitation and neurotoxicity during EtOH withdrawal (Butler
et al., 2013), whereas AMPA receptors have been shown to
play a key role in the regulation of reinforcement and the
reward process of EtOH (Stuber et al., 2008; Wang et al., 2012).
Preclinical research suggests the important role of metabotropic
glutamate subtype 5 (mGlu5) receptor in EtOH drinking (Cozzoli
et al., 2009, 2012; Besheer et al., 2010; Sinclair et al., 2012) and
in the memory formation responsible for the chronic relapsing
nature of alcohol abuse (Obara et al., 2009). Nevertheless, the
exact mechanisms by which ethanol exerts its toxic effects
through glutamatergic transmission are still unknown.
In the present study, we investigated the neurochemical
mechanisms underlying the toxicity induced by EtOH in
organotypic hippocampal slice models of dependence and/or
withdrawal. In particular, we investigated the role of ionotropic
and metabotropic glutamate receptors in mediating toxicity
induced by the chronic exposure to EtOH and following EtOH
withdrawal.
MATERIALS AND METHODS
Experiments and animal use procedures were in accordance
with the National Institutes of Health Guide for the Care
and Use of Laboratory Animals (NIH Publications No. 80-23,
revised 1996). The experimental protocols were approved by the
Animal Care Committee of the Department of Health Sciences,
section of Pharmacology, University of Florence, in compliance
with the European Convention for the Protection of Vertebrate
Animals used for Experimental and Other Scientific Purposes
(ETS no. 123), the Department of Neuroscience, Psychology,
Drug Research and Child Health (NeuroFarBa) (ETS no. 176) and
the European Communities Council Directive of 24 November
1986 (86/609/EEC). The authors further attest that all efforts
were made to minimize the number of animals used and their
suffering.
Materials
Propidium iodide (PI) was purchased from Sigma (St
Louis, MO, United States). Tissue culture reagents were
obtained from Gibco-BRL (San Giuliano Milanese, MI,
Italy) and Sigma (St Louis, MO, United States). 2,3-Dioxo-
6-nitro-1,2,3,4-tetrahydrobenzo[f ]quinoxaline-7-sulfonamide
disodium salt (NBQX) and 2-Methyl-6-(phenylethynyl)pyridine
(MPEP) hydrochloride were purchased from Tocris (Bristol,
United Kingdom).
Preparation of Rat Organotypic
Hippocampal Slice Cultures
Organotypic hippocampal slice cultures were prepared as
previously reported Gerace et al., 2012a, 2015, Landucci et al.,
2018). Briefly, hippocampi were removed from the brains of 7-
to 9-day old Wistar rat pups (Harlan, MI, Italy), transverse slices
(420 µm) were prepared using a McIlwain tissue chopper and
then transferred onto 30 mm diameter semiporous membranes
inserts (Millicell-CM PICM03050; Millipore, Italy), which were
placed in six well tissue culture plates containing 1.2 ml medium
per well. The culture medium consisted of 50% Eagle’s minimal
essential medium, 25% heat-inactivated horse serum, 25% Hanks’
balanced salt solution, 5 mg/ml glucose, 2 mM L-glutamine, and
3.75 mg/ml amphotericin B. Slices were maintained at 37 ◦C in
an incubator in atmosphere of humidified air and 5% CO2 for
10 days. Before experiments all slices were screened for viability
by incubating them for 30 min with PI (5µg/ml); slices displaying
signs of neurodegeneration were discarded from the study.
Ethanol Exposure and Drug Treatment in
Organotypic Hippocampal Slices
Rat organotypic hippocampal slice cultures were exposed for
7days to 100, 150, or 300 mM of EtOH (corresponding
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respectively to 4.6, 6.9, or 13.8 g/l) after 10 days of culture
in vitro as described in Gerace et al. (2016). The medium
was changed every day adding ethanol to the fresh culture
medium. After 7 days of EtOH treatment, some of the slices
were incubated in EtOH -free medium or in ethanol-free medium
plus the AMPA antagonist NBQX and/or the metabotropic
Glu5 antagonist MPEP for 24 h before they were assessed for
neuronal injury using PI fluorescence. As discussed (Gerace et al.,
2012b, 2016; Landucci et al., 2016), the concentrations of drugs
used in organotypic hippocampal slice experiments are generally
somewhat higher than those expected from their Kd values and
those used in cell cultures. This is due to the fact that they diffuse
slowly through the thickness of brain tissue in vitro. Moreover,
in the case of organotypic slices statically cultured on semiporous
membrane inserts at the interface between culture medium and
gas atmosphere, the concentrations of drugs need to be further
increased because only the bottom of the slice is exposed to
the bathing medium to which the drug is added and only a
fraction of the drug diffuses across the membrane and reaches
the tissue.
Assessment of CA1 Pyramidal Cell Injury
Propidium iodide (5 µg/ml) was added to the medium
either at the end of the 7-day EtOH incubation period
or 24 h after it was removed from the medium. Thirty
minutes later, fluorescence was viewed using an inverted
fluorescence microscope (Olympus IX-50; Solent Scientific,
Segensworth, United Kingdom) equipped with a xenon-arc
lamp, a low-power objective (4X) and a rhodamine filter.
Images were digitized using a video image obtained by a
CCD camera (Diagnostic Instruments Inc., Sterling Heights, MI,
United States) controlled by software (InCyt Im1TM; Intracellular
Imaging Inc., Cincinnati, OH, United States) and subsequently
analyzed using the Image-Pro Plus morphometric analysis
software (Media Cybernetics, Silver Spring, MD, United States).
In order to quantify cell death, the CA1 hippocampal subfield
was identified and encompassed in a frame using the drawing
function in the image software (ImageJ; NIH, Bethesda, MD,
United States) and the optical density of PI fluorescence was
detected. There was a linear correlation between CA1 PI
fluorescence and the number of injured CA1 pyramidal cells as
detected by morphological criteria (Pellegrini-Giampietro et al.,
1999).
Electron Microscopy in CA1 Region of
Hippocampal Slices
At the end of the experiments the slices were washed with cold
0.01 M phosphate-buffered saline, pH 7.4 and were directly fixed
in cold 4% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH
7.4) overnight at 4◦C and post-fixed in cold 1% osmium tetroxide
in 0.1 M phosphate buffer (pH 7.4) for 1 h at room temperature as
described in Gerace et al. (2016). The samples were dehydrated in
graded acetone, passed through propylene oxide, and embedded
in Epon 812. Ultrathin sections were stained with uranyl acetate
and alkaline bismuth subnitrate and examined under a JEM 1010
electron microscope (Jeol, Tokyo, Japan) at 80 kV.
Electrophysiological Recordings in
Organotypic Hippocampal Slices
Whole-cell voltage-clamp recordings were performed as
described in Gerace et al. (2016). Briefly, inward currents were
recorded in CA1 pyramidal cells from organotypic hippocampal
slices chronically treated with 150 mM of EtOH or under control
conditions. Slices were removed from the culture insert and
placed into a recording bath submerged with ice-cold artificial
cerebrospinal fluid (ACSF) containing (in mM): EtOH 150, NaCl
130, KCl 3.5, Na2H2PO4 3, NaHCO3, glucose, MgCl2 1.5 and
CaCl2 1.5 at pH 7.4 and oxygenated with 95%O2/5%CO2).
Recording microelectrodes were prepared from borosilicate
glass (WPI Inc; Sarasota, FL, United States) by a Narishige
Instruments micropipette puller (Tujunga, CA, United States)
(resistance ranging from 3 to 5 M) and filled with internal
solution of the following composition (in mM concentrations):
K-gluconate 142.5, potassium methylsulfate 20, NaCl 8, Hepes
10, EGTA 0.1, MgATP 2, and GTP 0.2. The pH of the internal
solution was adjusted to 7.2 with KOH and the osmolarity was
adjusted to 300 mOsm with H2O and sucrose. After establishing
a GIGA seal a whole-cell configuration was achieved by
rupturing the membrane. Recordings were done in voltage clamp
configuration (holding potentials −60 mV) using a Multiclamp
preamplifier (Axon Instruments; Foster City, CA, United States)
and filtered at 5 kHz. All the data were acquired, stored and
analyzed on a PC using the pCLAMP (Axon Instruments, Foster
City, CA, United States) and GraphPad softwares. Traces were
filtered by a digital Gaussian filter (Clampfit facility, low pass,
200 Hz). The frequency and peak amplitude of detected events
were analyzed using Mini Analysis Program (Synaptosoft Inc.,
Fort Lee, NJ, United States)1. The AMPA receptor blocker NBQX
(10 µM) was added at the end of each experiment to verify that
the spontaneous excitatory post synaptic currents were AMPA
receptor-mediated.
Western Blot Analysis
Cultured slices were washed with cold 0.01 M phosphate-buffered
saline, pH 7.4 and 8 slices/sample were gently transferred and
dissolved in a tube containing 1% SDS. Total protein levels were
quantified using the Pierce (Rockford, IL, United States) BCA
(bicinchoninic acid) Protein Assay. Forty µg of proteins were
resolved by electrophoresis on a 8 or 12% SDS-polyacrylamide
gel and transferred onto nitrocellulose membranes using the
transblot TURBO (Bio-Rad, Hercules, CA, United States). Blots
were probed overnight at 4◦C with the polyclonal rabbit vGluT1,
vGluT2, GluN2A, GluA1, metabotropic Glu1, PSD95, polyclonal
goat GluA2, GluN1 and monoclonal mouse metabotropic
Glu5 antibodies (Millipore, Italy), synaptophysin and GluN2B
antibodies (Thermo Scientific, Rockford, IL, United States),
C-terminal rabbit anti-CB1 polyclonal antibody (generously
provided by Dr. Ken Mackie, University of Washington, Seattle,
WA, United States), all diluted 1:1000 (Gerace et al., 2012b, 2016).
Immunodetection was performed with secondary antibodies
[1:2000 anti-mouse or anti-rabbit IgG from donkey or anti
1www.synaptosoft.com
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goat (Amersham Biosciences, United Kingdom) conjugated
to horseradish peroxidase. The reactive bands were detected
using chemiluminescence (ECLplus; Euroclone, Padova, Italy).
Quantitative analysis was performed using the QuantityOne
analysis software (Bio-Rad, Hercules, CA, United States).
Statistical Analysis
Data are presented as means ± SEM of n experiments. Statistical
significance of differences between PI fluorescence intensities or
Western blot optical densities was evaluated by performing one-
way ANOVA followed by Dunnet’s test for multiple comparisons
or by the Kolmogorov–Smirnov test (sEPSC recordings). All
statistical calculations were performed using GRAPH-PAD PRISM
v. 5 for Windows (GraphPad Software, San Diego, CA,
United States). A probability value (P) of < 0.05 was considered
significant.
RESULTS
Figure 1 shows that organotypic hippocampal slices exposed
to chronic EtOH for 7 days and then incubated in EtOH -
free-medium for the subsequent 24 h displayed a selective
and dose-dependent CA1 pyramidal necrotic cell death. The
concentrations of EtOH decreased within 24 h from 127 mM
(5.8 g/l) to 32 mM (1.5 g/l), which is similar to the blood
alcohol concentration detected in the blood of alcoholics in the
emergency room as shown in Gerace et al. (2016).
Electron microscopy confirmed what has been observed with
PI fluorescence and shows that after EtOH withdrawal the
slices undergo to neuronal death (Figures 2E,F). Moreover,
CA1 pyramidal cell bodies exposed to EtOH for 7 days
displayed suffering mithocondria, accumulation of lipofuscins
and intercellular empty spaces (Figure 2C,D) as compared to
control organotypic slices (Figures 2A,B), suggesting that not
only withdrawal but also 7 days chronic EtOH exposure elicited
signs of apoptotic cell death in CA1 pyramidal cells.
In order to understand the molecular mechanisms underlying
the toxicity induced by EtOH withdrawal in organotypic
hippocampal slices, we performed electrophysiological
experiments by using the patch clamp technique. We recorded
sEPSCs from CA1 pyramidal cells exposed to EtOH for 7 days
(as shown in Figure 3B) and during the first 30 min of EtOH
withdrawal. Figure 3A represents an example trace of the effect of
the AMPA antagonist NBQX on sEPSCs in control slice, showing
that under our experimental conditions sEPSCs are mainly if not
exclusively AMPA-mediated. We did not observe differences in
the holding current between control slices and slices chronically
exposed to EtOH for 7 days (100 ± 44 pA, n = 5 vs. 140 ± 32.6
pA, n = 5, respectively). Figure 3B show examples of sEPSCs
recorded under control conditions, after chronic incubation with
EtOH for 7-days and after 15 min of EtOH withdrawal. Our
results show that chronic EtOH exposure increases the amplitude
but not the frequency of sEPSCs (Figure 3). Interestingly,
EtOH withdrawal further increases sEPSCs amplitude without
affecting sEPSCs frequency compared to chronic EtOH exposure,
thus indicating that glutamatergic transmission is involved in
both EtOH dependence and withdrawal processes (Figure 3).
Kolmogorov–Smirnov analyses confirms that both the chronic
incubation with EtOH or its withdrawal produced a rightward
shift of the cumulative probability distribution of sEPSC
amplitude (Figure 3B, lower panel).
We then performed Western blotting analysis in organotypic
hippocampal slices exposed to EtOH using antibodies directed
against specific pre- and post-synaptic proteins (Figures 4, 5,
respectively). Chronic incubation with EtOH for 7 days and its
removal from the medium did not change the expression of
the presynaptic proteins vGluT1, vGluT2, CB1 receptors and
synaptophysin (Figure 4). On the other hand, at the postsynaptic
level, EtOH withdrawal induced an increased expression of the
AMPA subunit GluA1 and of the metabotropic Glu5 receptors,
while chronic EtOH exposure showed a trend toward an
increased expression without reaching a statistical significance
(Figures 5B,F) of the same proteins. No changes for NMDA
subunits (GluN1, GluN2A, and GluN2B) nor for the scaffold
protein PSD95, GluA2 AMPA subunit and mGluR1 receptors
were observed at the postsynaptic level (Figure 5) in both chronic
EtOH exposure and EtOH withdrawal.
These results propose a central role for AMPA and
metabotropic Glu5 receptors in EtOH -induced CA1 toxicity
and suggest AMPA and mGlu5 as possible therapeutic targets.
Therefore, we used a therapeutic approach in vitro by exposing
the slices to the AMPA competitive antagonist NBQX and to
the selective mGluR5 non-competitive antagonist MPEP during
the 24 h EtOH withdrawal period. We observed that both these
agents were able to significantly attenuate EtOH withdrawal-
induced neurotoxicity in the CA1 hippocampal subregion
(34 ± 2.7% and 26.7 ± 10.7% NBQX and MPEP, respectively)
(Figure 6) confirming that AMPA channels and mGlu5 receptors
are implicated in EtOH withdrawal injury.
DISCUSSION
In the present study, we investigated the neurochemical
mechanisms underlying the toxicity induced by EtOH in
organotypic hippocampal slice models of EtOH dependence
and/or withdrawal. Rat organotypic hippocampal slices (10 DIV)
were exposed for 7 days to concentrations of EtOH ranging
between 100 and 300 mM (corresponding to 4.6 and 13.8 g/l
respectively). As reported in Gerace et al. (2016), the actual
EtOH concentration measured in our culture media decreased
within 24 h from 127 mM (5.8 g/l) to 32 mM (1.5 g/l), which
reproduces the blood alcohol concentration oscillations typical
of a frequent drinker and is compatible with the high EtOH
peak concentrations (between 3 and 4 g/l) detected in the blood
of alcoholics in the emergency room. The slices were then
incubated in EtOH-free medium for the subsequent 24 h to
mimic EtOH withdrawal. Under these conditions, we observed
that EtOH withdrawal led to a dose-dependent CA1 pyramidal
necrotic cell death as detected by PI fluorescence and confirmed
by electron microscopy, revealing clear signs of injury in CA1
pyramidal cell bodies. Our results are in agreement with previous
studies showing neuronal damage and permanent impairment
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FIGURE 1 | Ethanol withdrawal induces cell death in mature organotypic hippocampal slices. (A) Experimental protocol showing hippocampal slices cultured for
10 days in vitro and exposed to 100, 150, 300 mM of ethanol (corresponding to 4.6, 6.9, or 13.8 g/l of plasmatic EtOH concentration in humans) for 7 days. At the
end of this period (Chronic ethanol), ethanol was removed from the medium. 24 h later (Withdrawal) the fluorescent dye propidium iodide (PI) was added to the
medium to assess neuronal injury. (B) Mature hippocampal slices, photographed under fluorescence optics, displaying background levels of fluorescence under
control or chronic ethanol condition (150 mM) and an intense PI labeling after ethanol withdrawal (150 mM), showing a selective CA1 pyramidal cell injury. (C) Cell
injury was assessed using the fluorescent dye propidium iodide at the end of the chronic EtOH treatment (150 mM) and after 24 h of EtOH withdrawal. Quantitative
data are expressed as CA1 PI fluorescence. Values represent the mean ± SEM of 5 experiments in ethanol withdrawal condition. ∗p < 0.05 and ∗∗p < 0.01 vs.
basal PI fluorescence (ANOVA + Dunnet’s test).
FIGURE 2 | Electron microscopic evidence for apoptotic cell death in organotypic hippocampal slices. (A,B) Control healthy CA1 pyramidal cells showing healthy
mithocondria (black arrow) and synapses rich in vescicles (white arrow) (A) and in longitudinally aligned microtubules in the neuronal processes (black asterisk) (B).
(C,D) CA1 pyramidal cells from chronic ethanol slices display suffering mithocondria (black arrow), accumulation of lipofuscins (white arrows) (C) and intercellular
empty spaces (black asterisk), but regular synapses (white arrow) and in longitudinally aligned microtubules in the neuronal processes (black arrow) (D). (E,F)
Electron microscope morphology in control organotypic slices showing normal synapses with presynaptic vescicles (white arrows) and in longitudinally aligned
microtubules in the neuronal processes (black asterisk) (E) and clear signs of apoptosis (black arrows) (F).
in synaptic transmission of hippocampal neurons (Prendergast
et al., 2000; Harris et al., 2003; Self et al., 2005).
Interestingly, a previous paper from our laboratory shows
that, under the same experimental conditions, the deprivation of
EtOH is not toxic in slices cultured for only 2 DIV, suggesting
that slices that have not reached complete maturation in vitromay
respond to prolonged EtOH incubation in a different manner as
compared to more mature slices, resulting in greater resistance
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FIGURE 3 | Chronic ethanol and ethanol withdrawal increase the amplitude of sEPSCs in CA1 pyramidal cells of organotypic hippocampal slices. Experiments were
conducted as described in Figure 1A. (A) Example trace showing the effect of the AMPA antagonist NBQX on sEPSCs recorded in CA1 pyramidal neurons of
control organotypic hippocampal slices in whole-cell voltage clamp configuration. (B) Representative traces showing sEPSCs recorded in CA1 pyramidal neurons of
organotypic hippocampal slices in whole-cell voltage clamp configuration under control, chronic ethanol incubation and ethanol withdrawal conditions.
(C) Cumulative probability plots demonstrating the effect of EtOH withdrawal on sEPSC interevent interval and amplitude. EtOH withdrawal caused a significant shift
in the amplitude distributions, indicating a significant increase in the amplitude of sEPSCs [Kolmogorov–Smirnov (K–S) statistic CRL vs. chronic EtOH and CRL vs.
EtOH withdrawal p < 0.0001]. On the contrary, the cumulative probability plots on sEPSC interevent interval did not show any significant changing (K–S statistic CRL
vs. chronic EtOH p = 0.977, CRL vs. EtOH withdrawal p = 0.462). Bar graphs displaying the values of sEPSC frequency (Hz) (D) and amplitude (pA) (E) during the
time course of the last 5 min of chronic ethanol treatment and the first 30 min of ethanol withdrawal. Bars represent the mean of at least 5 experiments.
∗∗∗p < 0.001 vs. CRL and ∗∗p < 0.01, ###p < 0.01 vs. chronic EtOH (ANOVA + Tukey’s w test). The number of cells is indicated on the bar graphs.
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FIGURE 4 | Chronic ethanol and ethanol withdrawal do not modify the expression of presynaptic proteins in organotypic hippocampal slices. Experiments were
conducted as described in Figure 1A. At the end of the experiments hippocampal slices were lysed and processed for Western blot. Top: representative Western
blots using antibodies against the pre-synaptic proteins vGlut1, vGlut2, CB1 and synaptophysin (A–D). The numbers on the left indicate the position of the molecular
mass markers (kDa). Tubulin was used as loading control. Bottom: quantitative analysis of immunoreactive bands, showing that chronic ethanol nor ethanol
withdrawal modify the expression of vGlut1, vGlut2, CB1 and synaptophysin. Data are expressed as percentage of control. Bars represent the mean ± SEM of at
least three experiments. ∗P < 0.05 vs. CRL (ANOVA + Dunnet’s test).
to EtOH toxicity upon its removal (Gerace et al., 2016). The
differential age-dependent effects of EtOH were highlighted also
by electron microscopy, which revealed, despite the lack of
toxicity observed with PI, a clear disorganization of microtubuli
in neural processes after chronic EtOH exposure in immature
slices (Gerace et al., 2016). On the contrary, microtubuli
alignment was observed in mature slices chronically exposed to
EtOH in the same CA1 neurons, but also ultrastructural signs of
neuronal suffering like distressed mitochondria, accumulation of
lipofuscins and intercellular empty spaces as compared to control
slices. These results suggest that not only withdrawal but also
chronic EtOH exposure may elicit signs of apoptotic cell death
in CA1 pyramidal cells.
These data are supported by our electrophysiological
recordings of AMPA-mediated sEPSCs from CA1 pyramidal
cells after 7 days of EtOH exposure and during the first 30 min
of EtOH removal, which revealed a significant increase in the
average amplitude but not in the frequency of sEPSCs that was
induced not only by EtOH withdrawal but was also present
in slices chronically exposed to EtOH, thus suggesting that
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FIGURE 5 | Ethanol withdrawal increases the expression of the GluA1 AMPA subunit and of mGluR5 proteins in organotypic hippocampal slices. Experiments were
conducted as described in Figure 1A. At the end of the experiments hippocampal slices were lysed and processed for Western blot. Top: representative Western
blots using antibodies against the post-synaptic proteins PSD95, GluN1, GluN2A, GluN2B, GluA1, GluA2, mGluR1, and mGluR5 (A–H). The numbers on the left
indicate the position of the molecular mass markers (kDa). Tubulin was used as loading control. Bottom: quantitative analysis of immunoreactive bands, showing that
ethanol withdrawal increases the expression of the AMPA subunit GluA1 and of metabotropic glutamate receptors mGluR5. Data are expressed as percentage of
control. Bars represent the mean ± SEM of at least three experiments. ∗P < 0.05 vs. CRL (ANOVA + Dunnet’s test).
glutamatergic post-synaptic transmission may be enhanced both
during EtOH dependence and following withdrawal. Several
reports have demonstrated that glutamatergic transmission
is involved in EtOH dependence and withdrawal (Läck et al.,
2007; Marty and Spigelman, 2012; Gerace et al., 2016). For
example, elevated levels of glutamate have been measured in
the medial prefrontal cortex of alcoholic patients and in nucleus
accumbens of alcohol-dependent rats during acute withdrawal
(Hermann et al., 2012; Pati et al., 2016). Our findings strongly
suggest that incubation with EtOH and/or its removal markedly
impair the structure and function of the excitatory post-synaptic
compartments. On the contrary, in immature organotypic
hippocampal slices EtOH induced a decrease in sEPSC frequency
and in the expression of specific presynaptic proteins, thus
suggesting an impairment of the structure and function of the
excitatory pre-synaptic compartments (Gerace et al., 2016).
Moreover, data obtained by Western blotting showing
that GluA1 and metabotropic Glu5 receptor expression levels
were significantly increased in slices following chronic EtOH
incubation and its withdrawal from the medium. On the contrary,
no changes in the expression of a number of presynaptic
proteins (vGlut1, vGlut2, CB1, and synaptophysin) nor of the
scaffold protein PSD95, the NMDA subunits GluN1, GluN2A
and GluN2B, the AMPA subunit GluA2 or mGlu1 receptors
were observed. Despite NMDA receptor alterations have been
described to contribute to neuronal excitation and neurotoxicity
following EtOH withdrawal (Butler et al., 2013), we failed
to observe any significant change in the expression of its
subunits GluN1, GluN2A, and GluN2B under our experimental
conditions. Rather, our findings show that following chronic
EtOH incubation and its withdrawal there is an increase in
AMPA-mediated sEPSCs and in the expression of the GluA1
AMPA subunit and mGlu5 receptors (Figure 7), in agreement
with reports demonstrating the implication of AMPA and
mGlu5 receptors in various models of EtOH dependence and
withdrawal. For example Varodayan et al. (2018) have shown that
AMPA receptor-mediated excitatory transmission is enhanced in
the medial prefrontal cortex of mice after chronic exposure to
EtOH followed by 1 week of withdrawal. Similarly Li et al. (2017)
have shown that the amplitude of AMPA EPSCs and GluA1
(S831) phosphorylation, that plays a crucial role in increasing
AMPAR activity in various regions of the brain (Malinow, 2003),
were increased in neurons of the lateral habenula after 24 h of
withdrawal from chronic voluntary EtOH drinking. Consistent
with these findings, AMPARs have been shown to play a key
role in the regulation of reinforcement and reward processes of
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FIGURE 6 | AMPA and mGluR5 antagonists attenuate the neurotoxicity induced by ethanol withdrawal in organotypic hippocampal slices. (A): Hippocampal slices,
photographed under fluorescence optics, displaying background levels of fluorescence under control conditions, an intense PI labeling in the CA1 subregion 24 h
after ethanol withdrawal, and a reduction of CA1 PI fluorescence when incubated with 10 µM NBQX and 30 µM of MPEP during the 24 h withdrawal period. (B):
Quantitative analysis of CA1 region expressed as percentage of CRL PI fluorescence. Incubation with the AMPA antagonist NBQX and with the selective mGluR5
antagonist MPEP significantly attenuated ethanol-withdrawal-induced injury. Values represent the mean ± SEM of at least five experiments. ∗∗∗P < 0.001 vs. CRL
and # < 0.05 vs. ethanol withdrawal alone and ## < 0.01 vs. ethanol withdrawal alone (ANOVA + Tukey’s w test).
FIGURE 7 | Hypothetical model to explain mechanisms underlying ethanol withdrawal toxicity. Ethanol withdrawal potentiates the excitatory synaptic transmission
that lead to CA1 injury of hippocampus in vitro. These alterations are probability due to the increase of the expression of the glutamate receptors AMPA (specifically
the GluA1 AMPA subunit) and mGluR5. These evidences suggest that after ethanol withdrawal there is a shift in AMPAR subunit composition with the insertion of
calcium permeable AMPA receptors in organotypic hippocampal slices.
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EtOH (Stuber et al., 2008; Wang et al., 2012), presumably via an
EtOH-dependent increase in the surface concentration of GluA1
subunits in the striatum. As for mGlu5 receptors, a significant
increase in its gene expression was observed in the amygdala
and in the nucleus accumbens shell of EtOH-withdrawn rats
(Kumar et al., 2016; Lee et al., 2018). Moreover, preclinical
research suggests an important role of this receptor subtype in
EtOH drinking (Cozzoli et al., 2009, 2012; Besheer et al., 2010;
Sinclair et al., 2012) and in memory formation, which appears
to be responsible for the chronic relapsing nature of alcohol
abuse (Obara et al., 2009). In fact, mGlu5 has been implicated in
cognition (e.g., memory and learning), novelty seeking behavior,
and compulsivity, all factors that may be important in the
susceptibility to drug addiction (Leurquin-Sterk et al., 2018).
We observed that both the AMPA competitive antagonist
NBQX and the selective mGluR5 non-competitive antagonist
MPEP were able to significantly attenuate EtOH withdrawal-
induced neurotoxicity in the CA1 hippocampal sub-region,
confirming the central role of AMPA channels and mGlu5
receptors in EtOH withdrawal hippocampal injury. The present
findings support the results from reports showing that AMPA and
mGlu5 receptor antagonists are involved in EtOH-withdrawal-
related behaviors. For example, pharmacological inhibition of
AMPA receptors reduces EtOH consumption in rats (Li et al.,
2017) and the systemic administration of mGlu5 antagonists
attenuate cue-evoked reinstatement of ethanol-seeking behavior
in rodents (Bäckström and Hyytiä, 2004; Adams et al., 2008;
Hodge et al., 2008; Sinclair et al., 2012). Similarly, studies
with mGlu5 negative allosteric modulators performed in animal
models of addiction have shown a reduction in the self-
administration of cocaine, ethanol, and nicotine (Mihov and
Hasler, 2016). Finally, our Western blot results show an
increase in the expression of GluA1 but not GluA2 AMPA
subunits in hippocampal slices following EtOH withdrawal,
suggesting a shift in AMPA receptor subunit composition,
from GluA2-containing to GluA2-lacking calcium-permeable
channels that could explain the CA1 injury observed in our
slices following EtOH-withdrawal. An increase in GluA2-lacking
calcium-permeable AMPA channels has been shown to promote
cell death of hippocampal CA1 pyramidal neurons in models of
toxicity (Anzai et al., 2003; Gerace et al., 2014) and in pathological
conditions including global ischemia (Pellegrini-Giampietro
et al., 1997) and amyotrophic lateral sclerosis (Hideyama and
Kwak, 2011). Calcium-permeable AMPA receptors have also been
demonstrated to play an important role in addiction models
(Mameli et al., 2011; Pascoli et al., 2014): for example, it
was recently shown that cocaine-induced potentiation of VTA
synapses is mediated by the insertion of calcium permeable
AMPA receptors to the synaptic membranes (Mills et al.,
2017).
CONCLUSION
Our data suggest that chronic EtOH treatment promotes
abnormal synaptic transmission that may lead to CA1 pyramidal
cell death after EtOH withdrawal through glutamate receptors
and increased excitotoxicity. In addition, we propose AMPA and
mGlu5 receptors as two candidate targets for new therapeutic
interventions for alcohol addiction.
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